Search

Research

Research in hematology has dramatically improved our understanding of hematologic diseases and resulted in many innovative, groundbreaking discoveries.

Read more

Childcare services

EHA is pleased to offer complimentary professional childcare services for registered Congress participants’ children throughout the duration of the EHA2025 Congress.

Read more

Pomalidomide prolongs survival in refractory myeloma patients

MM-003 is a large, multi-centre phase 3 study that assessed the efficacy and safety of a new drug, Pomalidomide (POM) in combination with low-dose dexamethasone (POM+LoDex) and compared this combination with high dose dexamethasone in MM patients with late stage…

Read more

EHA-EMBL/EBI Computational Biology Training in Hematology

The CBTH 2025 call for applications is now closed.

Read more

General Information

June 5, 2025
EHA2025 Congress platform opens

June 12-15, 2025
EHA2025 Milan, Italy - In-person and live stream

Location 
Allianz MiCo, Milano Convention Centre

August 15, 2025
EHA2025 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof.

Read more